Search FZMD
Fuse Medical, Inc.
OTC · CIK 319016
Last close0.03
Daily change+0.01 (50.00%)
10 Years gain-80.00%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
FZMD · STANDARD
SIC 5047 · Wholesale-Medical, Dental & Hospital Equipment & Supplies · Fiscal year end 1231
Fundamental
24.3Momentum
100.0Acceleration
100.0Confidence
63.0Annual Revenue10
Quarterly Revenue35
Annual CFO12
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth0.5 / 25
Quality19.3 / 25
Capital Efficiency0.0 / 20
Balance Sheet3.4 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5
Signals
Gross margin expansionGross margin improved by 6.4747 percentage points.
Operating leverageOperating margin improved by 10.2649 percentage points.
Net debt reductionNet debt declined versus the comparison period.
Warnings
Receivables anomaly · MEDIUMAccounts receivable growth is materially above revenue growth.
Heavy share dilution · HIGHDiluted share count increased 10.9585%.
Low interest coverage · HIGHInterest coverage is -0.1698x.
Key Metrics
Revenue Growth TTM-3.83%OK
Revenue CAGR 3Y-6.62%OK
Gross Margin65.87%OK
Operating Margin-0.18%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROICn/aMISSING
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y10.96%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2022 FY Dec 31, 2022 | $18.64M | $11.54M | -$815,072.00 | $34,799.00 | n/a | 61.9% | -4.37% | n/a | n/a | 77.86M |
| 2022 FY Dec 31, 2021 | $20.41M | $11.94M | -$2.20M | -$1.78M | n/a | 58.47% | -10.75% | n/a | n/a | 70.32M |
| 2021 FY Dec 31, 2020 | $21.40M | $12.70M | -$1.03M | $236,654.00 | $215,897.00 | 59.37% | -4.8% | 1.01% | n/a | 70.22M |
| 2020 FY Dec 31, 2019 | $22.90M | $11.14M | -$4.35M | -$4,739.00 | -$20,057.00 | 48.63% | -19% | -0.09% | n/a | 70.22M |
| 2019 FY Dec 31, 2018 | $26.34M | $12.99M | -$1.96M | $2.48M | $2.44M | 49.31% | -7.43% | 9.26% | n/a | 73.93M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $18.19M | sum latest 4 fiscal quarters Revenue | OK | 0001437749-23-023606, 0001564590-22-037641 |
| Revenue Growth TTM | -3.83% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001437749-23-023606, 0001564590-22-037641 |
| Revenue CAGR 3Y | -6.62% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001564590-23-005716 |
| Revenue CAGR 5Y | -6.72% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001564590-23-005716 |
| Gross Profit CAGR 3Y | 1.2% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001564590-23-005716 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | 0001437749-23-023606, 0001564590-23-007256 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 65.87% | Gross Profit / Revenue | OK | 0001437749-23-023606, 0001564590-22-037641 |
| Operating Margin | -0.18% | Operating Income / Revenue | OK | 0001437749-23-023606, 0001564590-22-037641 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001437749-23-023606 |
| Interest Coverage | -0.17x | Operating Income / abs(Interest Expense) | OK | derived |
| Current Ratio | 1.06x | Current Assets / Current Liabilities | OK | derived |
| Revenue per Diluted Share | $0.23 | Revenue / Diluted Shares | OK | 0001437749-23-023606, 0001564590-22-037641 |
| SBC / FCF | n/a | SBC / FCF | NOT_MEANINGFUL | derived |